Good practice in the assessment and management of nocturnal Parkinson's disease symptoms

Age and Ageing

Volumn 34, Issue 5, 2005, Pages 435-438

  Medcalf, Pippa ^a  

^a CHESTERFIELD ROYAL HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIHYPERTENSIVE AGENT; APOMORPHINE; BENZODIAZEPINE DERIVATIVE; CABERGOLINE; CAFFEINE; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; DESMOPRESSIN; DIURETIC AGENT; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; OXYBUTYNIN; QUETIAPINE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; TOLTERODINE; TRICYCLIC ANTIDEPRESSANT AGENT; VASODILATOR AGENT;

BEHAVIOR DISORDER; COGNITIVE DEFECT; CONFUSION; DEPRESSION; DRUG INFUSION; ELECTROMYOGRAM; EPWORTH SLEEPINESS SCALE; GOOD LABORATORY PRACTICE; HALLUCINATION; HUMAN; INSOMNIA; NOCTURIA; NONREM SLEEP; NOTE; ORTHOSTATIC HYPOTENSION; PANIC; PARKINSON DISEASE; PERSONAL HYGIENE; PRIORITY JOURNAL; PSYCHOSIS; REM SLEEP; RESTLESS LEGS SYNDROME; SLEEP DISORDER; TREATMENT INDICATION;

AGED; HUMANS; PARKINSON DISEASE; SLEEP DISORDERS;

EID: 24644520373     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/afi157     Document Type: Note

References (17)

1. Gulati A, Forbes A, Stegie F et al. A clinical observational study of pattern and occurrence of non-motor symptoms in Parkinson's disease. Mov Disord 2004; 19(Suppl 9): S406 (P1187).
2. Happe S, Lüdemann, Berger K. The association between disease severity and sleep-related problems in patients with Parkinson's disease. Neuropsychobiology 2002; 46: 90-6.
3. Kelly L. Pilot questionnaire among members of the Parkinson's Disease Society UK. 2004 (personal communication).
4. Roth T, Rye DB, Borchert LD et al. Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists. Sleep Med 2003; 4: 275-80.
5. Newman AB, Spiekerman DF, Enright P et al. Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group. J Am Geriatr Soc 2000; 48: 115-23.
6. Arnulf I, Konofal E, Merino-Andreu M et al. Parkinson's disease and sleepiness: An integral part of PD. Neurology 2002; 58: 1019-24.
7. Asada T, Motonaga T, Yamagata Z et al. Association between retrospectively recalled napping behaviour and later development of Alzheimer's disease: Association with APOE genotypes. Sleep 2000; 23: 629-34.
8. Homann CN, Wenzek K, Suppan K et al. Sleep attacks in patients taking dopamine agonists: Review. BMJ 2002; 324: 1483-7.
9. Chaudhuri KR, Bhattacharya K, Agapito C et al. The use of cabergoline in nocturnal parkinsonian disabilities causing sleep disruption: A parallel study with controlled-release levodopa. Eur J Neurol 1999; 6(Suppl 5): S11-S15.
10. Pal PK, Thennarsu K, Fleming J et al. Nocturnal sleep disturbances and daytime dysfunction in patients with Parkinson's disease and in their caregivers. Parkinsonism Rel Disord 2004; 10: 157-68.
11. Smith MC, Ellgring H, Oertel WH. Sleep disturbance in Parkinson's disease patients and spouses. J Am Geriatr Soc 1999; 45: 194-9.
12. Wisor JP, Nishino S, Sora I et al. Dopaminergic role in stimulant-induced wakefulness. J Neuroscience 2001; 21: 1787-94.
13. Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 2002; 8: 193-7.
14. Johns MW. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep 1991; 14: 540-5.
15. Chaudhuri KR, Pal S, DiMarco A et al. The Parkinson's disease sleep scale: A new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002; 73: 629-35.
16. Chaudhuri KR. Nocturnal symptom complex in PD and its management. Neurology 2003; 61(Suppl 3): S17-S23.
17. Reuter I, Ellis CM, Chaudhuri KR. Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome. Acta Neurol Scand 1999; 100: 163-7.